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Objective. To evaluate antinocicpetive and redox properties of the monoterpenes (+)-camphene, p-cymene, and geranyl acetate in
in vivo and in vitro experimental models. Methods. Evaluation of the in vitro antioxidant activity of (+)-camphene, p-cymene,
and geranyl acetate using diﬀerent free radical-generating systems and evaluation of antinociceptive actions by acetic acid-
induced writhing and formalin-induced nociception tests in mice. Results. p-Cymene has the strongest antinociceptive eﬀect, but
(+)-camphene and geranyl acetate also present signi�cant activity at high doses (200mg/kg). (+)-Camphene had the strongest
antioxidant eﬀect in vitro at TBARS and TRAP/TAR assays and also had the highest scavenging activities against diﬀerent free
radicals, such as hydroxyl and superoxide radicals. Sodium nitroprussiate-derived NO production was enhanced by (+)-camphene.
Geranyl acetate and p-cymene also presented some antioxidant eﬀects, but with a varying pro�le according the free radical-
generating system studied. Conclusion. (+)-Camphene, p-cymene, and geranyl acetate may present pharmacological properties
related to in�ammation and pain-related processes, being potentially useful for development of new therapeutic strategies, with
limited possibilities for p-cymene and geranyl acetate.
1. Introduction
In developing countries and/or areas inhabited by indigenous
populations, plants and other natural sources constitute the
solely source of bioactive molecules used for a variety of
purposes. e use of medicinal plants throughout thousands
of years by these populations allowed accumulation of empir-
ical knowledge of their utility, which demands adequate
evaluation of eﬃcacy, safety, and action mechanisms [1].
e therapeutic properties of certain medicinal plants are
generally related to their content of secondary metabolites,
such as polyphenols, terpenes, phytosteroids, and alkaloyds,
among others, which are produced in considerable amounts
and variable proportions [2]. Essential oils are concentrated
volatile aromatic compounds produced by aromatic plants,
such as Cymbopogon winterianus Jowitt (Poaceae), Cymbo-
pogon citrates Stapf (Poaceae), �avandula multi�da Linnaeus
(Lamiaceae), and ymus pubescens Boiss. Et Kotschy ex
Celak (Lamiaceae) that have been found to exhibit a variety
of biological properties [3–6]. Monoterpenes are the main
chemical constituents of the essential oils of these plants and
are found as mixtures of odoriferous components that can
be obtained by steam distillation or solvent extraction from
a large variety of aromatic plants. ey are found in edible as
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well as in medicinal plants with a therapeutic property [7–
10].
Recent works have demonstrated that monoterpenes
may present important pharmacological properties includ-
ing antimicrobial [11], antioxidant [3], analgesic [12], and
antitumoral [9] activities, as well as eﬀects on cardiovascular
system [13] and central nervous system (CNS) [14]. (+)-
camphene, p-cymene, and geranyl acetate (Figure 1) are
monoterpenes present in the essential oils of various plant
species, such as Cypress, Origanum, and Eucalyptus oils [15,
16]. ese substances are present at signi�cant amounts in a
wide variety of products derived from natural sources used
as food, medicines, or other purposes in diﬀerent countries.
However, reports with reference to their therapeutic eﬀects
by studies aiming to establish their individual characteristics,
as described in the present work, are scarce in literature.
Oxidative stress is the result of an unbalance in reactive
species production and antioxidant defense and is a main
component in cancer, infectious diseases, cardiovascular
disorders, and neurodegenerative conditions [17]. Pharma-
cological agents showing therapeutic eﬃciency against some
diseases may exert antioxidant properties in target tissues,
which may be related to their mechanism of action [18].
Monoterpenes isolated from medicinal plants have been
previously described as redox-active molecules, being able to
scavenge speci�c reactive species such as hydroxyl radicals
and nitric oxide (NO), preventing oxidation of biomolecules
and in�uencing pain and in�ammation [3, 19, 20]. Since
reactive species and oxidative stress are linked to a wide array
of pathological conditions, the evaluation of the redox action
ofmonoterpeneswith potential pharmacological activitymay
indicate new pharmacological agents for such diseases.
In the present work, we performed a screening of
redox activities and antinociceptive actions of the monoter-
penes (+)-camphene, p-cymene, and geranyl acetate. ese
monoterpenes are active compounds isolated from several
medicinal plants traditionally used in Brazil and also in other
countries to treat a wide range of chronic and/or infectious
diseases related to pain, in�ammation, and oxidative stress
[13]. Studies with plant extracts or other products containing
one or more of these substances have been conducted
previously, but conclusions on the potential properties of
their isolated constituents are highly limited due the presence
of several metabolites in these preparations.
2. Material andMethods
2.1. Chemicals. Acetic acid, (+)-camphene (95% purity),
p-cymene (≥97% purity), geranyl acetate (98% purity)
(Figure 1), polyoxyethylene-sorbitan monolate (Tween 80),
AAPH (2,2′-Azobis(2-methylpropionamidine)dihydrochlo-
ride), luminol (5-amino-2,3-dihydro-1,4-phthalazinedione),
2-deoxyribose, glycine, Griess reagent, SNP (sodium ni-
troprusside), TBA (2-thiobarbituric acid), (4,6-dihydroxy-
pyrimidine-2-thiol), H2O2 (hydrogen peroxide), adrenaline,
catalase, and SOD (superoxide dismutase) were purchased
from Sigma (USA). Diazepam and aspirin were purchased
from União Química (Brazil). All other reagents used in this
study were of analytical or HPLC grade.
2.2. Animals. Adult male albino Swiss mice (28–34 g) were
randomly housed in appropriate cages at 21 ± 2∘C with a
12/12-h light/dark cycle (light from 06:00 to 18:00), with
free access to food (Purina, Brazil) and tap water. We used
6–8 animals in each group. Nociceptive tests were carried
out by the same visual observer and all eﬀorts were made
to minimize the number of animals used as well as any
discomfort. Experimental protocols were approved by the
Animal Care and Use Committee (CEPA/UFS no. 26/09) at
the Federal University of Sergipe.
2.3. Acetic Acid-Induced Writhing. We followed the proce-
dure by Koster et al. [21]. Mice (𝑛𝑛 𝑛 𝑛, per group) were
pretreated either by (+)-camphene, p-cymene, or geranyl
acetate (50, 100 or 200mg/kg), acetylsalicylic acid (Aspirin,
200mg/kg), and the vehicle (saline + Tween-80 0.3%) by
intraperitoneal route (i.p.). en, aer 1 h, mice received
the 0.65% acetic acid injection (i.p., 0.25mL/animal). Each
animal was placed in an individual observation chamber, and
15 minutes aer acetic acid injection the cumulative number
of writhing responses was recorded for 15 minute aer a
latency period of 5 minutes.
2.4. Formalin-Induced Nociception. e procedure described
by Hunskaar and Hole [22] was used. Nociception was
induced by injecting 20 𝜇𝜇L of 1% formalin in distilled water
in the right hind paw subplantar. Mice (𝑛𝑛 𝑛 𝑛, per group)
previously received the same treatments described in the
writhing test (1 h prior to injecting formalin). ese mice
were individually placed in a transparent plexiglass cage
observation chamber (25 cm × 15 cm × 15 cm). e amount
of time each animal spent licking the injected pawwas indica-
tive of pain. e number of lickings from 0–5min (early
phase) and 15–30min (late phase) were counted aer forma-
lin injection. is volume and percentage concentration of
formalin were selected from our pilot studies that showed a
pain-related biphasic behavioral response (face-rubbing) of
great intensity at periods of 0–5 minutes (�rst phase) and
15–40 minutes (second phase). Pain was quanti�ed at those
periods by measuring the time (in seconds) that the animals
spent facerubbing in the injected area with their fore- or
hindpaws.
2.5. Total Reactive Antioxidant Potential (TRAP) and Total
Antioxidant Reactivity (TAR). e total reactive antioxidant
potential (TRAP) is employed to estimate the nonenzymatic
antioxidant capacity of samples in vitro.is method is based
on the quenching of luminol-enhanced chemiluminescence
(CL) derived from the thermolysis of AAPH as the free
radical source [23]. Brie�y, we prepared AAPH solution,
added luminol (AAPH + luminol, free radical-generating
system) and then waited the system to stabilize for 2 h before
the �rst reading. Diﬀerent concentrations of each substance
were added and the luminescence produced by the free
radical reactionwas quanti�ed in a luminescence plate reader
(Microbeta 1450, Perkin Elmer, Boston, MA, USA) during
60min. e results were transformed in percentage and area
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F 1: Chemical structure of (+)-camphene, p-cymene, and geranyl acetate.
under curve (AUC) and calculated in the GraphPad Prism
version 5.01 soware.
e total antioxidant reactivity (TAR) was also analyzed
in the same samples used for TRAP readings.eTAR results
were calculated as the ratio of light intensity in absence
of samples (I0)/light intensity right aer sample addition.
Although TAR and TRAP evaluations are obtained in the
same experiment, they represent diﬀerent observations, since
the TAR is more related to the antioxidant quality (reactivity,
the scavenging capacity in a short-term period) and TRAP is
more related to the antioxidant amount and kinetic behavior.
2.6. Hydroxyl Radical-Scavenging Activity. e formation of
•OH (hydroxyl radical) from Fenton reaction was assessed
using the 2-deoxyribose oxidative degradation assay. e
principle of the assay is the incubation of 2-deoxyribose
with a hydroxyl radical generation system, which produces
malondialdehyde (MDA).is system is then incubated with
2-thiobarbituric acid (TBA), which reacts with MDA and
forms a chromophore quanti�able by spectrophotometry
[24]. Brie�y, typical reactions were started by the addi-
tion of Fe2+ (FeSO4 6 𝜇𝜇M �nal concentration) to solutions
containing 5mM2-deoxyribose, 100mMH2O2, and 20mM
phosphate buﬀer (pH 7.2).
To measure the antioxidant of activity of each compound
against hydroxyl radicals, diﬀerent concentrations of (+)-
camphene, p-cymene, and geranyl acetate were added to
the system before Fe2+ addition. Reactions were carried out
for 15min at room temperature and were stopped by the
addition of 4% phosphoric acid (v/v) followed by 1% TBA
(w/v, in 50mMNaOH). Solutions were boiled for 15min at
95∘C and then cooled at room temperature. e absorbance
was measured at 532 nm and results were expressed as
percentage of TBARS formed.
2.7. Nitric Oxide (NO•) Scavenging Activity. NO scavenging
activity was quanti�ed as previously described [25]. NO
was generated from spontaneous decomposition of sodium
nitroprusside (SNP) in 20mM phosphate buﬀer (pH 7.4).
Once generated, NO interacts with oxygen to produce nitrite
ions, which were measured by the Griess reaction. e
reaction mixture (1mL) containing 10mMSNP and either
(+)-camphene, p-cymene, or geranyl acetate at diﬀerent
concentrations were incubated at 37∘C for 1 h. An aliquot
of 0.5mL was taken and homogenized with 0.5mL Griess
reagent. e absorbance of chromophore was measured
at 540 nm. Results were expressed as percentage of nitrite
formed by SNP alone.
2.8. iobarbituric Acid-Reactive Species (TBARS). iobar-
bituric acid-reactive substances (TBARS) assaywas employed
to quantify lipid peroxidation and an adaptedTBARSmethod
was used tomeasure the antioxidant capacity of themonoter-
penes using egg yolk homogenate as lipid rich substrate [19].
e principle of the method is based on spectrophotometric
measurement of the color produced during the reaction of
thiobarbituric acid (TBA) with lipoperoxidation products,
such as malondialdehyde and 4-hydroxynonenal. Brie�y,
egg yolk was homogenized (1% w/v) in 20mM phosphate
buﬀer (pH 7.4), 1mL of homogenate was sonicated and
then homogenized with 0.1mL of (+)-camphene, p-cymene,
or geranyl acetate at diﬀerent concentrations. Lipid per-
oxidation was induced by addition of 0.1mL of AAPH
solution (0.12M). Control was the incubation medium
without AAPH. Reactions were carried out for 30min at
37∘C. Samples (0.5mL) were centrifuged with 0.5mL of TCA
15% at 1200×g for 10min. An aliquot of 0.5mL from the
supernatant was mixed with 0.5mL TBA (0.67%) and heated
at 95∘C for 30min. Aer cooling, samples absorbance was
measured using a spectrophotometer (UV-1800 Shimadzu) at
532 nm. e results were expressed as percentage of TBARS
formed by AAPH alone “induced control”.
2.9. Superoxide-Dependent Adrenaline Autooxidation (“SOD-
Like” Activity). e ability of (+)-camphene, p-cymene, and
geranyl acetate to scavenge superoxide anion (“superoxide
dismutase-like” activity or “SOD-like” activity) wasmeasured
as previously described [26]. Samples were mixed with
200 𝜇𝜇L glycine buﬀer (50mM, pH 10.2) and 5 𝜇𝜇L of native
catalase 100U/mL. Superoxide generation was initiated by
addition of adrenaline 2mM and adrenochrome formation
was monitored at 480 nm for 5 minutes at 32∘C. Superoxide
production was determined by monitoring the reaction
curves of samples and measured as percentage of the rate of
adrenaline autooxidation into adrenochrome.
2.10. Catalase-Like Activity. e capacity of (+)-camphene,
p-cymene, and geranyl acetate to degrade hydrogen peroxide
(H2O2) added in the incubation medium (“catalase-like” or
“CAT-like” activity) was measured as previously described
[25]. Brie�y, H2O2 diluted in 0.02M phosphate buﬀer
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(pH 7.0), to obtain a 5mM �nal concentration, was added
to microplate wells, in which diﬀerent concentrations of
(+)-camphene, p-cymene, and geranyl acetate were present.
Readings were made in a spectrophotometric plate reader
(SpectraMax 190-Molecular Devices) at 240 nm every 15
seconds for 5 minutes at 37∘C. Catalase-like activity was
monitored based on the rate decomposition of H2O2. Data
were expressed as percentage of the rate decomposition of
H2O2.
2.11. Statistical Analysis. Data were evaluated using Graph-
Pad Prism version 5.01 (Graph Pad Prism Soware Inc., San
Diego, CA, USA), through analysis of variance (ANOVA)
followed by Tukey’s test. e results are presented as mean ±
S�M. In all cases, the diﬀerences were considered signi�cant
if 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃.
3. Results
3.1. Acetic Acid-Induced Writhing. All tested doses of p-
cymene produced signi�cantly (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 or 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃)
antinociceptive eﬀect in this test compared to control group
(vehicle) (Table 1). Pretreatment with (+)-camphene or
geranyl acetate, at higher doses, signi�cantly reduced no-
ciceptive behavior compared with control group. Aspirin
(200mg/kg), used as positive control, also produced a signif-
icant antinociceptive eﬀect (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃).
3.2. Formalin-Induced Pain. e highest doses of either (+)-
camphene or geranyl acetate caused a signi�cant inhibition
of the licking response to the injected paw in mice, compared
with the control group, only in the second phase of the
formalin test (Table 1). However, p-cymene, in all doses,
signi�cantly inhibited (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 or 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃) both
phases of formalin test when compared with control group.
Additionally, p-cymene-treated mice were more signi�cantly
protected when compared with (+)-camphene or geranyl
acetate-treated animals. As expected, aspirin (200mg/kg)
reduced the licking time only in second phase.
3.3. Rotarod Test. Monoterpene-treated mice did not show
any signi�cant motor performance alterations with the doses
of 200mg/kg (Figure 2). As might be expected, the CNS
standard depressant diazepam (5mg/kg, i.p.) reduced the
time of treated animals on the rotarod apparatus (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃)
compared with the control group.
3.4. Lipid Peroxidation. To evaluate the antioxidant prop-
erties of three monoterpenes, we �rst assessed the ability
of each compound to prevent lipid peroxidation in an in
vitro peroxyl-generating system. (+)-camphene prevented
lipoperoxidation induced by AAPH (Figure 3(a)). Geranyl
acetate also presented antioxidant activity (Figure 4(a)). On
the other hand, p-cymene had no eﬀect on AAPH-induced
lipoperoxidation (Figure 5(a)).
3.5. TRAP and TAR Parameters. To further explore the redox
pro�le of these compounds, the TRAP/TAR parameters were
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evaluated, which indicate the capacity of a given sample
to act as a general antioxidant or prooxidant agent in a
constant reactive species generating system. We observed
that (+)-camphene presents a signi�cant antioxidant activity,
which was indicated by both TRAP and TAR parame-
ters (Figures 3(b) and 3(c)). On the other hand, geranyl
acetate did not present antioxidant activity; in fact, a sig-
ni�cant prooxidant eﬀect was observed in the TRAP assay
(Figures 4(b) and 4(c)). p-Cymene had no eﬀect towards
antioxidant or prooxidant activity in both TRAP and TAR
measurements (Figures 5(b) and 5(c)).
3.6. Redox Activities against Isolated Free Radicals. (+)-
camphene, geranyl acetate, and p-cymene all presented sig-
ni�cant antioxidant activity against hydroxyl radicals gen-
erated in vitro, although at varying degrees (Figures 3(d),
4(d) and 5(d)). Besides, (+)-camphene presented a dose-
dependent activity of NO generation in relation to control
(Figure 3(e)), while geranyl acetate (Figure 4(e)) and p-
cymene (Figure 5(e)) had no eﬀect towards NO forma-
tion or scavenging activity. (+)-Camphene also presented
increased SOD-like activity, indicating ability to scavenge or
inhibit superoxide radicals (Figure 3(f)). Geranyl acetate, on
the other hand, enhanced superoxide-mediated adrenaline
oxidation (Figure 4(f)), while p-cymene had no statisti-
cally signi�cant eﬀect (Figure 5(f)). Finally, the CAT-like
assay demonstrated that (+)-camphene (Figure 3(g)) and p-
cymene (Figure 5(g)) have a modest, although signi�cant,
activity against H2O2, while geranyl acetate had no eﬀect
(Figure 4(g)).
4. Discussion
Our results showed that the monoterpenes here evaluated
are able to inhibit the nociceptive behavior in mice, as
determined by a signi�cant reduction in acetic acid-induced
abdominal writhing. Acetic acid-induced abdominal con-
striction is a standard, simple, and sensitive test for mea-
suring analgesia induced by both central and peripherally
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F 5: In vitro evaluation of the redox pro�le of p-cymene. (a) TBARS in vitro assay for lipid peroxidation assessment. (b) TRAP and (c)
TAR values. (d) Hydroxyl radical-scavenging activity assay. (e) Nitric oxide (NO) scavenging assay. (f) Superoxide dismutase-like (SOD-like)
activity. (g) Catalase-like (CAT-like) activity. Vehicle was DMSO 0.1% in all tests; in NO-scavenging activity, SOD-like and CAT-like activity
tests, control is DMSO 0.1% alone. Bars represent mean ± SEM values. ∗𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃, ∗∗𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃, ∗∗∗𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃𝑃 (1-way ANOVA followed by
Tukey’s post-hoc test).
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T 1: Eﬀect of (+)-camphene, 𝑝𝑝-cymene, geranyl acetate, or aspirin on writhing induced by acetic acid and formalin-induced nociception
tests.
Treatment Dose (mg/kg) Writhing test Formalin test
Number of writhingsa 0–5mina 15–30mina
Vehicle — 27.8 ± 3.1 85.7 ± 8.8 113.8 ± 28.6
(+)-Camphene 50 22.5 ± 5.3 76.1 ± 9.6 107.1 ± 11.2
(+)-Camphene 100 25.1 ± 4.7 81.7 ± 8.3 68.3 ± 14.7b
(+)-Camphene 200 15.7 ± 4.4c 72.4 ± 12.8 44.3 ± 11.9c
𝑝𝑝-Cymene 50 8.9 ± 5.9c 43.5 ± 7.1b,&,# 49.4 ± 9.5c
𝑝𝑝-Cymene 100 4.1 ± 0.9d,&,# 24.0 ± 8.9d,&,# 33.5 ± 10.0d
𝑝𝑝-Cymene 200 1.3 ± 0.5d,&,# 11.9 ± 5.1d,&,# 25.4 ± 7.4d,&,#
Geranyl acetate 50 23.9 ± 5.7 77.0 ± 11.4 98.7 ± 16.6
Geranyl acetate 100 13.0 ± 4.8c 65.9 ± 13.2 55.4 ± 9.1c
Geranyl acetate 200 15.7 ± 3.6c 79.9 ± 10.3 59.3 ± 11.2c
Aspirin 200 5.1 ± 3.2d 78.3 ± 17.8 27.5 ± 11.1d
n = 8, per group.
aValues represent mean ± SEM.
b𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃, c𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 or d𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 (one-way ANOVA and Turkey�s post hoc test), signi�cantly diﬀerent from control group.
&𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 or 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 (one-way ANOVA and Turkey�s post hoc test), signi�cantly diﬀerent from (+)-camphene-treated group.
#𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 or 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 (one-way ANOVA and Turkey�s post hoc test), signi�cantly diﬀerent from geranyl acetate-treated group.
acting analgesics [22, 27]. In acetic acid-induced abdominal
writhing, pain is elicited by the injection of an irritant such
as acetic acid into the peritoneal cavity, which produces
episodes of characteristic stretching (writhing) movements,
and inhibition of the number of episodes by analgesics is
easily quanti�able [27]. To investigate if the treatments with
(+)-camphene, p-cymene, or geranyl acetate could in�uence
themotor activity of the animals and consequently impair the
assessment of the nociceptive behavior in the experimental
models, the motor activity of the animals was evaluated with
a rotarod apparatus [28]. Monoterpenes-treated mice did
not show any signi�cant motor performance change when
evaluated in rotarod test. Results showed in the present work
support the hypothesis of (+)-camphene, p-cymene, and ger-
anyl acetate participation in the inhibition of prostaglandin
(PGE) synthesis, as the nociceptive mechanism involves
the process or release of arachidonic acid metabolites via
cyclooxygenase (COX) and PGE biosynthesis [29] during
abdominal writhing induced by acetic acid.
e formalin test is a very useful method for not only
assessing antinociceptive drugs but also helping in the elu-
cidation of their action mechanisms. e neurogenic phase,
commonly denominated �rst phase, is probably a direct result
of paw stimulation and re�ects centrally mediated pain with
release of substance P while the late phase is due to the release
of histamine, serotonin, bradykynin and prostaglandins [27].
Only p-cymene was able to reduce nociceptive behavior in
both phases of the formalin test. e second phase, denom-
inated �in�ammatory phase,� depends on a combination of
ongoing inputs from nociceptive aﬀerents, due to the release
of excitatory amino acids, PGE2, NO, tachykinin, and kinins
among other peptides and, at least in part, of central sensitiza-
tion [30, 31]. Additionally, intraplanar injection of formalin
has been described to induce the production and release
of NO [32], which in turn is suggested to be an essential
component of the proin�ammatory/nociceptive response by
the stimulation of the production and release of cytokines,
reactive species, and prostanoids [33]. On the other hand,
it is generally agreed that N-methyl-D-aspartate (NMDA)
receptors contribute to the persistent chemical stimulus
during the late phase of central sensitization of dorsal horn
neurons [34]. Our results show that monoterpenes produced
an inhibition of the in�ammatory pain, later phase, inmice as
determined by a signi�cant reduction of nociceptive behavior
in second phase of formalin test.
Apparently (+)-camphene and geranyl acetate demon-
strated a discrete analgesic pro�le when compared with p-
cymene. In fact, some analgesic eﬀects of p-cymene were
previously demonstrated by our group [35]. We here com-
pared this activity with other monoterpenes and attempted
to establish a correlation of anti-in�ammatory and analgesic
eﬀects of these compounds with their redox properties, as
it is suggested for other monoterpenes [3]. Monoterpenes
with oxygen in their structure constitute a wide group of
antioxidant molecules, largely due to their functional groups
(alcohols) [18].
We performed a detailed screening of the redox prop-
erties of these monoterpenes to establish their antioxidant
properties, as reactive oxygen/nitrogen species (ROS/RNS)
mediate in�ammatory processes and are involved in the
molecular mechanisms of several pathologies [36]. Ter-
penoids exhibiting antioxidant properties have been con-
sidered potential candidates for new therapeutic agents,
especially when found in medicinal plants traditionally used
to treat ROS/RNS-related diseases. Although p-cymene had
a stronger antinociceptive eﬀect, when compared to the
other terpenes, this compound exhibited a poor antioxidant
potential in vitro. p-Cymene did not prevent AAPH-induced
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lipoperoxidation, suggesting it is not able to act as a mem-
brane antioxidant; besides, TRAP and TAR parameters did
not show any eﬀect of p-cymene on the in vitro free radical-
generating system. High concentrations of p-cymene had a
modest eﬀect against H2O2 and hydroxyl radicals; however, it
did not preventNOand superoxide radicals formation, which
are reactive species more related to pain and in�ammation
[36]. Hydroxyl radical has a high oxidant power and it is
probably the most reactive radical [37]. It is able to join DNA
nucleotides and cause strand breakage, which contributes to
carcinogenesis, mutagenesis, and cytotoxicity. Nevertheless,
(+)-camphene had a pronounced antioxidant eﬀect at TBARS
assay, which was con�rmed at TRAP/TAR measurements,
CAT-like activity and hydroxyl-scavenging assays. Further-
more, (+)-camphene presented signi�cant superoxide degra-
dation activity but enhanced NO formation. Geranyl acetate
had amixed redox pro�le, with antioxidant activity in TBARS
and hydroxyl-scavenging assays and prooxidant activity at
TRAP/TARmeasurements and SOD-like activity assay, while
the NO-scavenging assay showed no activity.
NO is a dual molecule playing major roles in both cell
signaling and oxidative/nitrosative stress in a concentration
and time-dependent manner [37, 38]. is molecule may
be physiologically generated through NO synthases activity,
triggering anti-in�ammatory and cytoprotective pathways.
However, NO also may increase the synthesis/release of
proin�ammatory mediators such as cytokines and reactive
oxygen species [39] and prostanoids [33], thus promoting
in�ammatory reaction. We observed that (+)-camphene
enhanced NO production in vitro, and our in vivo results
show that (+)-camphene has a modest antinociceptive activ-
ity. Peripherally released NO contributes to the development
of oedema and hyperalgesia in tissue injury and in�am-
mation [36]. As mentioned above, expression of several
inducible enzymes that contribute to the release of proin�am-
matory mediators such as NO and PGE2 are observed during
in�ammation, such as inducible nitric oxide synthase (iNOS)
and cyclooxygenase-2 (COX-2). COX-2 is the inducible form
of the enzyme, the synthesis ofwhich is triggered by cytokines
that also induce iNOS.e two pathways interact closely and
NO can stimulate COX-2 activity by combiningwith its heme
component [40].
e monoterpene p-cymene had no activity against NO,
but presented the highest antinociceptive eﬀect. Antioxidant
properties are generally associated to “bene�cial” eﬀects,
mainly due to the widespread association between free
radicals with diseases and ageing. However, when a given
substance presents little or none antioxidant activity at one
or several in vitro assays, this may not be associated to lack
of therapeutic properties. is apparent contradiction may
rely on the fact that interaction of NO with other reactive
species results in loss of its regulatory properties; for instance,
NO-mediated activation of COX and subsequent release of
bene�cial and anti-in�ammatory prostaglandins is lost when
superoxide production is also enhanced, since interaction
between superoxide and NO leads to in situ formation
of peroxynitrite, a potent cytotoxic and proin�ammatory
reactive species [36, 37]. Although p-cymene had no eﬀect
against NO, we observed a mild activity against superoxide at
SOD-like activity assay, which may attenuate NO deleterious
eﬀects and preserve its bene�cial properties.
5. Conclusion
We show here a screening of antinociceptive actions and
redox properties of threemonoterpenes isolated frommedic-
inal plants. Assays with animals demonstrated that p-cymene
has the strongest antinociceptive eﬀect, but (+)-camphene
and geranyl acetate also present signi�cant activity at higher
doses. However, (+)-camphene had the strongest antioxidant
eﬀect at TBARS and TRAP/TAR assays, and also had the
highest scavenging activities against diﬀerent free radicals
generated by in vitro systems. Geranyl acetate and p-cymene
also presented some antioxidant eﬀect, but with a varying
pro�le according the free radical-generating system studied.
e results presented here suggest that (+)-camphene, p-
cymene, and geranyl acetate may present pharmacological
properties related to in�ammation and pain-related pro-
cesses, being potentially useful for development of new
therapeutic strategies, with limited possibilities for p-cymene
and geranyl acetate.
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